Acidosis mediates recurrent hypoglycemia-induced increase in ischemic brain injury in treated diabetic rats

Neuropharmacology. 2018 Jun:135:192-201. doi: 10.1016/j.neuropharm.2018.03.016. Epub 2018 Mar 15.

Abstract

Objectives: Cerebral ischemia is a serious possible manifestation of diabetic vascular disease. Recurrent hypoglycemia (RH) enhances ischemic brain injury in insulin-treated diabetic (ITD) rats. In the present study, we determined the role of ischemic acidosis in enhanced ischemic brain damage in RH-exposed ITD rats.

Methods: Diabetic rats were treated with insulin and mild/moderate RH was induced for 5 days. Three sets of experiments were performed. The first set evaluated the effects of RH exposure on global cerebral ischemia-induced acidosis in ITD rats. The second set evaluated the effect of an alkalizing agent (Tris-(hydroxymethyl)-aminomethane: THAM) on ischemic acidosis-induced brain injury in RH-exposed ITD rats. The third experiment evaluated the effect of the glucose transporter (GLUT) inhibitor on ischemic acidosis-induced brain injury in RH-exposed ITD rats. Hippocampal pH and lactate were measured during ischemia and early reperfusion for all three experiments. Neuronal survival in Cornu Ammonis 1 (CA1) hippocampus served as a measure of ischemic brain injury.

Findings: Prior RH exposure increases lactate concentration and decreases pH during ischemia and early reperfusion when compared to controls. THAM and GLUT inhibitor treatments attenuated RH-induced increase in ischemic acidosis. GLUT inhibitor treatment reduced the RH-induced increase in lactate levels. Both THAM and GLUT inhibitor treatments significantly decreased ischemic damage in RH-exposed ITD rats.

Conclusions: Ischemia causes increased acidosis in RH-exposed ITD rats via a GLUT-sensitive mechanism. Exploring downstream pathways may help understand mechanisms by which prior exposure to RH increases cerebral ischemic damage.

Keywords: CA1 hippocampus; Global cerebral ischemia; Glucose transporter; Ischemic acidosis; Lactate.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acidosis / pathology
  • Acidosis / physiopathology*
  • Acrylamides / pharmacology
  • Animals
  • Brain Ischemia / pathology
  • Brain Ischemia / physiopathology*
  • CA1 Region, Hippocampal / drug effects
  • CA1 Region, Hippocampal / pathology
  • CA1 Region, Hippocampal / physiopathology
  • Central Nervous System Agents / pharmacology
  • Diabetes Mellitus, Experimental / pathology
  • Diabetes Mellitus, Experimental / physiopathology*
  • Glucose Transport Proteins, Facilitative / antagonists & inhibitors
  • Glucose Transport Proteins, Facilitative / metabolism
  • Hydrogen-Ion Concentration
  • Hypoglycemia / pathology
  • Hypoglycemia / physiopathology*
  • Lactic Acid / metabolism
  • Male
  • Random Allocation
  • Rats, Wistar

Substances

  • Acrylamides
  • Central Nervous System Agents
  • Glucose Transport Proteins, Facilitative
  • tris(hydroxymethyl)-acrylamidomethane
  • Lactic Acid